Oppenheimer Asset Management Inc. Purchases 5,224 Shares of CME Group Inc. (NASDAQ:CME)

Oppenheimer Asset Management Inc. lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 19.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 32,531 shares of the financial services provider’s stock after acquiring an additional 5,224 shares during the period. Oppenheimer Asset Management Inc.’s holdings in CME Group were worth $6,396,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. Gold Investment Management Ltd. bought a new position in CME Group in the 4th quarter valued at approximately $26,000. Salomon & Ludwin LLC bought a new position in CME Group in the 1st quarter valued at approximately $28,000. Y.D. More Investments Ltd bought a new position in CME Group in the 2nd quarter valued at approximately $36,000. McClarren Financial Advisors Inc. lifted its stake in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the last quarter. Finally, Asset Dedication LLC lifted its stake in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on CME. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. upped their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Barclays upped their price target on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Finally, Piper Sandler restated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research report on Tuesday, August 20th. Four investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $209.73.

CME Group Trading Down 0.1 %

CME opened at $216.99 on Monday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $223.80. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a fifty day moving average of $205.69 and a 200-day moving average of $207.50. The stock has a market cap of $78.13 billion, a PE ratio of 24.69, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period last year, the company posted $2.30 earnings per share. On average, sell-side analysts predict that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.12%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.